000			01576 a2200469 4500
005			20250511214324.0
264		0	_c19900412
008			199004s 0 0 eng d
022			_a0002-9343
024	7		_a10.1016/0002-9343(90)90279-m _2doi
040			_aNLM _beng _cNLM
100	1		_aPierce, M W
245	0	0	_aEfficacy of estazolam. The United States clinical experience. _h[electronic resource]
260			_bThe American journal of medicine _cMar 1990
300			_a6S-11S p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnti-Anxiety Agents _xtherapeutic use
650	0	4	_aAnxiety Disorders _xdrug therapy
650	0	4	_aChronic Disease
650	0	4	_aClinical Trials as Topic
650	0	4	_aDepressive Disorder _xdrug therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aEstazolam _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMulticenter Studies as Topic
650	0	4	_aPlacebos
650	0	4	_aSleep _xdrug effects
650	0	4	_aSleep Initiation and Maintenance Disorders _xdrug therapy
650	0	4	_aTime Factors
650	0	4	_aUnited States
700	1		_aShu, V S
773	0		_tThe American journal of medicine _gvol. 88 _gno. 3A _gp. 6S-11S
856	4	0	_uhttps://doi.org/10.1016/0002-9343(90)90279-m _zAvailable from publisher's website
999			_c1974907 _d1974907